Mealey's (September 4, 2020, 12:57 PM EDT) -- CHICAGO — A federal judge in Illinois on Sept. 1 ruled that shareholders in a securities class action lawsuit against AbbVie Inc. and two of its senior executives have sufficiently pleaded the necessary elements of their federal securities laws claims in alleging that the defendants misrepresented the biopharmaceutical company's growth and success of its rheumatoid arthritis prescription medication, Humira, and their alleged failure to disclose their involvement in a kickback scheme with physicians (Mayuko Holwill v. AbbVie Inc., et al., No. 18-6790, N.D. Ill., 2020 U.S. Dist. LEXIS 159885)....